Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223

被引：0
|
作者：
dos Reis, Rodolfo Borges [1 ]
Muglia, Valdair [2 ]
Faria, Eliney F. [3 ,4 ]
机构：
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cirurgia & Anat, Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Imagens Med Radioterapia & Oncohematol, Ribeirao Preto, SP, Brazil
[3] Hosp Felicio Rocho, Belo Horizonte, MG, Brazil
[4] Hosp Amor Barretos, Dept Urol, Barretos, SP, Brazil
来源：
INTERNATIONAL BRAZ J UROL | 2020年 / 46卷 / 04期
关键词：
D O I：
10.1590/S1677-5538.0343.1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 50 条
  • [21] Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer
    Anido-Herranz, Urbano
    Fernandez-Calvo, Ovidio
    Ruiz-Banobre, Juan
    Martinez-Breijo, Sara
    Fernandez-Nunez, Natalia
    Nogareda-Seoane, Zulema
    Garrido-Pumar, Miguel
    Casas-Nebra, Javier
    Muniz-Garcia, Gloria
    Portela-Pereira, Paula
    Gomez-Caamano, Antonio
    Perez-Fentes, Daniel Adolfo
    Santome-Couto, Lucia
    Lazaro, Martin
    Molina-Diaz, Aurea
    Medina-Colmenero, Ana
    Vazquez-Estevez, Sergio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)
    Hijab, A.
    Tunariu, N.
    Tovey, H.
    Alonzi, R.
    Tree, A.
    Staffurth, J.
    Blackledge, M.
    Padhani, A. R.
    Stidwill, H.
    Finch, J.
    Chatfield, P.
    Perry, S.
    Koh, D-M.
    Hall, E.
    Parker, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S539 - S539
  • [23] Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Peters, Michel L.
    de Meijer, Claudine
    Wyndaele, Dirk
    Noordzij, Walter
    Leliveld-Kors, Annemarie M.
    van den Bosch, Joan
    van den Berg, Pieter H.
    Baka, Agni
    Gaultney, Jennifer G.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (01) : 133 - 143
  • [24] Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging
    Iizuka, Junpei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 16 - 23
  • [25] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [26] Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
    Al-Ezzi, Esmail Mutahar
    Alqaisi, Husam
    Picardo, Sarah
    Iafolla, Marco
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Catton, Charles
    Warde, Padraig
    Hamilton, Robert James
    Fleshner, Neil Eric
    Zlotta, Alexandre
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
    Al-Ezzi, E. M. M.
    Alqaisi, H. A.
    Iafolla, M.
    Sridhar, S.
    Sacher, A.
    Fallah-Rad, N.
    Jiang, D. M.
    Catton, C.
    Warde, P.
    Hamilton, R.
    Fleshner, N.
    Zlotta, A.
    Hansen, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S537 - S538
  • [28] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    van der Doelen, Maarten J.
    Stockhaus, Agnes
    Ma, Yuanjun
    Mehra, Niven
    Yachnin, Jeffrey
    Gerritsen, Winald R.
    Nilsson, Sten
    van Oort, Inge M.
    Ullen, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) : 3325 - 3334
  • [29] Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223
    Al-Ezzi, Esmail M.
    Alqaisi, Husam A.
    Iafolla, Marco A. J.
    Wang, Lisa
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Jiang, Di M.
    Watson, Geoffrey A.
    Catton, Charles N.
    Warde, Padraig R.
    Hamilton, Rob J.
    Fleshner, Neil E.
    Zlotta, Alexandre R.
    Hansen, Aaron R.
    CANCER MEDICINE, 2021, 10 (17): : 5775 - 5782
  • [30] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    Maarten J. van der Doelen
    Agnes Stockhaus
    Yuanjun Ma
    Niven Mehra
    Jeffrey Yachnin
    Winald R. Gerritsen
    Sten Nilsson
    Inge M. van Oort
    Anders Ullén
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3325 - 3334
12345